Allergic Conjunctivitis

Oncology·MeSH: Conjunctivitis, Allergic

12 drugs in development·8 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
loteprednol etabonate	Amneal Pharmaceuticals, Inc. (AMRX)
Ocular Immunoglobulin E (IgE)	AXIM BIOTECHNOLOGIES, INC. (AXIM)
zerviate	HARROW, INC. (IMMY)

Phase 3(6)

Drug	Company
regn1908	REGENERON PHARMACEUTICALS, INC. (REGN)
regn1909	REGENERON PHARMACEUTICALS, INC. (REGN)
regn5713	REGENERON PHARMACEUTICALS, INC. (REGN)
regn5715	REGENERON PHARMACEUTICALS, INC. (REGN)
reproxalap	Aldeyra Therapeutics, Inc. (ALDX)
vehicle	Aldeyra Therapeutics, Inc. (ALDX)

Phase 2(2)

Drug	Company
prt2761	PORTOLA PHARMACEUTICALS INC (PTLA)
vsj-110	Vanda Pharmaceuticals Inc. (VNDA)

Preclinical(1)

Drug	Company
allereye	Bluejay Diagnostics Inc. (BJDX)

BioSniper tracks 12 drugs in development for Allergic Conjunctivitis across 8 companies.

There are 2 clinical trials targeting Allergic Conjunctivitis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.